openPR Logo
Press release

Biosimilar Drug Market Analysis, Size, Trends AND Forecast to 2025: Lanxess AG, Solvay S.A., CF Industries, Holdings, Inc., Ma'aden-Saudi Arabian Mining Company, OCP SA

03-30-2020 06:30 PM CET | Health & Medicine

Press release from: Report Hive Research

Biosimilar Drug Market

Biosimilar Drug Market

As healthcare costs continue to rise, biosimilars offer new therapeutic options with the potential for cost savings to the healthcare system. With anticipated savings, biosimilars bring hope that there will be expanded access for patients to not only these known therapies, but also to new innovative medicines. At Amgen, serving patients is at the core of what we do and it is why we're using our more than 35 years of biologics experience to develop high-quality biosimilars.

Biosimilar Drug Market research report offers a detailed Outlook and future prospects of the Industry. The Biosimilar Drug Market report includes various topics like market size & share, Product types, applications, key market drivers & restraints, challenges, growth opportunities, key players, competitive landscape.

Download PDF Sample of this Report @ https://www.reporthive.com/enquiry.php?id=1547143&req_type=smpl

Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA.

First, in pharmerging markets, both governments and patients struggle to pay for biosimilars, which encouraged the demand of biosimilars, therefore in the future the biosimilars will grow around 20%.

Second, generally, biosimilars industry is still in their infancy in China. It is commonly believed that the next 10 to 15 years is the golden period of the development of biosimilars.

Third, for the biosimilars industry, technical barriers will be much smaller, in the next few years, there will be more and more enterprises going into biosimilars industry.

Forth, most of biosimilars manufacturer are concentrated in US, Germany, UK and other developed countries.

Market Segment by Manufacturers, this report covers:
Amgen
Eli Lilly
Novartis
CP Guojian Pharma
Biotech Pharma

This report focuses on the Biosimilar Drug Marketin global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa.

Market Segment by Type, covers
Injection
Tablets
Other Types

Market Segment by Applications, can be divided into
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
Other Application

Click Here for Purchase Full Report with Full TOC @ https://www.reporthive.com/checkout?currency=single-user-licence&reportid=1547143

Table of Contents
1 Market Overview
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.1.1 Amgen Description
2.1.1.2 Amgen Headquarter, Main Business and Finance Overview
2.1.2 Amgen Biosimilar Drug Product Introduction
2.1.2.1 Biosimilar Drug Production Bases, Sales Regions and Major Competitors
2.1.2.2 Biosimilar Drug Product Information
2.1.3 Amgen Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Amgen Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Amgen Biosimilar Drug Market Share in 2017

2.2 Eli Lilly
2.2.1 Business Overview
2.2.1.1 Eli Lilly Description
2.2.1.2 Eli Lilly Headquarter, Main Business and Finance Overview
2.2.2 Eli Lilly Biosimilar Drug Product Introduction
2.2.2.1 Biosimilar Drug Production Bases, Sales Regions and Major Competitors
2.2.2.2 Biosimilar Drug Product Information
2.2.3 Eli Lilly Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Eli Lilly Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Eli Lilly Biosimilar Drug Market Share in 2017

2.3 Novartis
.....................
12 Biosimilar Drug Market Forecast (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix

500, North Michigan Avenue,
Suite 6014
Chicago, IL - 60611
United States
Contact Us
Mike Ross
Marketing Manager
sales@reporthive.com
https://www.reporthive.com
Phone Number: +1-312 604 7084

About Report Hive Research
Report Hive Research delivers strategic market research reports, statistical survey, and Industry analysis & forecast data on products & services, markets and companies. Our clientele ranges mix of global Business Leaders, Government Organizations, SME's, Individual & Start-ups, Management Consulting Firms, and Universities etc. Our library of 600,000+ market reports covers industries like Chemical, Healthcare, IT, Telecom, Semiconductor, etc. in the USA, Europe Middle East, Africa, Asia Pacific. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales & revenue, technology trends, competitive analysis, product portfolio & application analysis etc.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biosimilar Drug Market Analysis, Size, Trends AND Forecast to 2025: Lanxess AG, Solvay S.A., CF Industries, Holdings, Inc., Ma'aden-Saudi Arabian Mining Company, OCP SA here

News-ID: 1991123 • Views:

More Releases from Report Hive Research

Oryzenin Market 2022 scope and Research methodology | Axiom Foods, Inc., AIDP
Oryzenin Market 2022 scope and Research methodology | Axiom Foods, Inc., AIDP
The global Oryzenin market is expected to reach an estimated USD 561.1 Million by 2030 with a CAGR of 14.2% from 2022 to 2030. The Global Oryzenin market 2022 research provides a overview of the industry including definitions, classifications, applications and industry chain structure. The Global Oryzenin market report is provided for the US, EU, APAC, as well as development trends, competitive landscape analysis, and key regions development status. Development policies
Polymer Emulsions Market SWOT Analysis, Competitive Landscape and Massive Growth 2022 | BASF, Dow, Trinseo(Styron)
Polymer Emulsions Market SWOT Analysis, Competitive Landscape and Massive Growth …
The global Polymer Emulsions market was estimated at USD 27.3 billion in 2021 and is projected to expand at a CAGR of 7.5% from 2022 to 2030. The Report Hive Research has added a new statistical market report to its repository titled as, Polymer Emulsions Market. It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; cost, revenue, demands, and supply data
Glufosinate Market Future Set to Significant Growth with High CAGR value 2022 | Bayer CropScience, Lier Chemical, Zhejiang YongNong
Glufosinate Market Future Set to Significant Growth with High CAGR value 2022 | …
The global Glufosinate market is expected to reach an estimated USD 4.12 billion by 2030 with a CAGR of 8.68% from 2022 to 2030. The Glufosinate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product
Glass Filled Nylon Market 2022 scope and Research methodology | DowDuPont, BASF, Asahi Kasei
Glass Filled Nylon Market 2022 scope and Research methodology | DowDuPont, BASF, …
The global Glass Filled Nylon market is projected to register an average CAGR of 5.6% during the forecast period 2022-2030. The Global Glass Filled Nylon market 2022 research provides a overview of the industry including definitions, classifications, applications and industry chain structure. The Global Glass Filled Nylon market report is provided for the US, EU, APAC, as well as development trends, competitive landscape analysis, and key regions development status. Development policies

All 5 Releases


More Releases for Biosimilar

Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market? In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market? In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial
Biosimilar Market Treating More for Less: The Booming Infliximab Biosimilar Mark …
Infliximab Biosimilar Market worth $ XX Million by 2030 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Infliximab Biosimilar Market- by Application (Crohn's Disease, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Ankylosing Spondylitis, Plaque Psoriasis and Others), End User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Direct Distribution Channels), Trends, Industry Competition Analysis, Revenue and Forecast To 2030." Get
Biosimilar Monoclonal Antibodies Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Biosimilar Monoclonal Antibodies Market by Product (infliximab, trastuzumab, rituximab, adalimumab, bevacizumab, cetuximab, ranibizumab, denosumab, eculizumab, and other pipeline products), Indication (oncology, inflammatory & autoimmune disorders, chronic diseases, blood disorders, and other indications), Clinical Trial/Pipeline Analysis, Future Trends, Industry Competition Analysis, Revenue and Forecast To 2031." The Biosimilar Monoclonal Antibodies Market Size is valued at 5.02
Infliximab Biosimilar Insight, 2023 | DelveInsight
DelveInsight's, "Infliximab Biosimilar Insight, 2023" report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in Infliximab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Interested to know more about the functioning of
Infliximab Biosimilar Insight, 2022 | DelveInsight
DelveInsight's, "Infliximab Biosimilar Insight, 2022" report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in Infliximab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Interested to know more about the functioning of